Press release
Nanomedicine Market worth $425.88 billion by 2030, growing at a CAGR of 10.91% - Exclusive Report by 360iResearch
The "Nanomedicine Market by Molecule Type (Nanodevices, Nanoparticles, Nanoshells), Modality (Diagnostics, Treatment), Application, Indication - Global Forecast 2024-2030" report has been added to 360iResearch.com's offering.
The Global Nanomedicine Market to grow from USD 206.25 billion in 2023 to USD 425.88 billion by 2030, at a CAGR of 10.91%.
Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/nanomedicine?utm_source=openpr&utm_medium=referral&utm_campaign=sample
Nanomedicine is a branch of medicine that employs the knowledge and tools of nanotechnology to prevent and treat diseases. The nanomedicine market encompasses various applications, including drug delivery, in vivo imaging, in vitro diagnostics, biomaterials, and active implants. This market is driven by integrating nanoscale technologies into medicine, offering novel methods to diagnose and treat several illnesses with heightened efficacy and minimized adverse effects. Additionally, technological advancements in particle design, increased investments in nanotechnology research, and the consequent regulatory approvals are the factors promoting the utilization of nanomedicine in clinical trials. However, the nanomedicine market faces multiple challenges, including the high cost and complexity of nanomedicine development, issues surrounding the toxicity and biocompatibility of nanoparticles, and the lack of a clear regulatory framework. Furthermore, there are limitations associated with the large-scale manufacturing of nanomedicines and ensuring the stability of nanoparticles. The latest opportunities in nanomedicine are witnessed in personalized medicine, where nanotechnology is employed to tailor treatments according to individual genetic profiles. There is increasing interest in nanobots for precision surgery, targeted therapy, and nanoparticles for immune system modulation. Biodegradable nanostructures offer an environmentally friendly alternative for drug delivery vehicles. Nanofabrication techniques are also expected to revolutionize regenerative medicine by creating nanostructured scaffolds for tissue regeneration.
FPNV Positioning Matrix:
The FPNV Positioning Matrix is essential for assessing the Nanomedicine Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).
Market Share Analysis:
The Market Share Analysis offers an insightful look at the current state of vendors in the Nanomedicine Market. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.
Key Company Profiles:
The report delves into recent significant developments in the Nanomedicine Market, highlighting leading vendors and their innovative profiles. These include AMAG Pharmaceuticals, Inc., Amgen Inc., Arrowhead Pharmaceuticals, Inc., Bausch Health Companies Inc., Bayer Healthcare, Biogen Inc., Bristol-Myers Squibb Company, Celgene Corporation, Eisai Co Ltd, F. Hoffmann-La Roche AG, Galen Ltd, General Electric Company, Gilead Sciences, Inc., Ipsen SA, Jazz Pharmaceuticals plc, Lantheus Holdings, Inc., Leadient BioSciences Inc., Mallinckrodt Pharmaceuticals, Merck & Co., Inc., Nano spectra Biosciences, Inc., Novo Nordisk A/S, OSARTIS GmbH, Pacira BioSciences Inc., Pfizer Inc., Sanofi S.A., Taiwan Liposome Company, Ltd., Takeda Pharmaceutical Company Limited, Teva Pharmaceuticals Ltd., UCB SA, and Zimmer Biomet Holdings, Inc..
Inquire Before Buying @ https://www.360iresearch.com/library/intelligence/nanomedicine?utm_source=openpr&utm_medium=referral&utm_campaign=inquire
Market Segmentation & Coverage:
This research report categorizes the Nanomedicine Market in order to forecast the revenues and analyze trends in each of following sub-markets:
Based on Molecule Type, market is studied across Nanodevices, Nanoparticles, Nanoshells, and Nanotubes. The Nanoparticles is further studied across Dendrimers, Hydrogel Nanoparticles, Inorganic Nanoparticles, Liposomes, Metal & Metal Oxide Nanoparticles, and Polymers & Polymer Drug Conjugates. The Nanotubes is projected to witness significant market share during forecast period.
Based on Modality, market is studied across Diagnostics and Treatment. The Diagnostics is projected to witness significant market share during forecast period.
Based on Application, market is studied across Diagnostic Imaging, Drug Delivery, Implants, Regenerative Medicine, and Vaccines. The Regenerative Medicine is projected to witness significant market share during forecast period.
Based on Indication, market is studied across Clinical Cardiology, Clinical Oncology, Immunology, Infectious Diseases, Neurology, Ophthalmology, Orthopedics, and Urology. The Orthopedics is projected to witness significant market share during forecast period.
Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Asia-Pacific is projected to witness significant market share during forecast period.
Key Topics Covered:
1. Preface
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
6. Nanomedicine Market, by Molecule Type
7. Nanomedicine Market, by Modality
8. Nanomedicine Market, by Application
9. Nanomedicine Market, by Indication
10. Americas Nanomedicine Market
11. Asia-Pacific Nanomedicine Market
12. Europe, Middle East & Africa Nanomedicine Market
13. Competitive Landscape
14. Competitive Portfolio
15. Appendix
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Nanomedicine Market?
2. Which are the products/segments/applications/areas to invest in over the forecast period in the Nanomedicine Market?
3. What is the competitive strategic window for opportunities in the Nanomedicine Market?
4. What are the technology trends and regulatory frameworks in the Nanomedicine Market?
5. What is the market share of the leading vendors in the Nanomedicine Market?
6. What modes and strategic moves are considered suitable for entering the Nanomedicine Market?
Read More @ https://www.360iresearch.com/library/intelligence/nanomedicine?utm_source=openpr&utm_medium=referral&utm_campaign=analyst
Contact 360iResearch
Mr. Ketan Rohom
Sales & Marketing,
Office No. 519, Nyati Empress,
Opposite Phoenix Market City,
Vimannagar, Pune, Maharashtra,
India - 411014.
sales@360iresearch.com
+1-530-264-8485
+91-922-607-7550
About 360iResearch
360iResearch is a market research and business consulting company headquartered in India, with clients and focus markets spanning the globe.
We are a dynamic, nimble company that believes in carving ambitious, purposeful goals and achieving them with the backing of our greatest asset - our people.
Quick on our feet, we have our ear to the ground when it comes to market intelligence and volatility. Our market intelligence is diligent, real-time and tailored to your needs, and arms you with all the insight that empowers strategic decision-making.
Our clientele encompasses about 80% of the Fortune Global 500, and leading consulting and research companies and academic institutions that rely on our expertise in compiling data in niche markets. Our meta-insights are intelligent, impactful and infinite, and translate into actionable data that support your quest for enhanced profitability, tapping into niche markets, and exploring new revenue opportunities.
The Global Nanomedicine Market to grow from USD 206.25 billion in 2023 to USD 425.88 billion by 2030, at a CAGR of 10.91%.
Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/nanomedicine?utm_source=openpr&utm_medium=referral&utm_campaign=sample
Nanomedicine is a branch of medicine that employs the knowledge and tools of nanotechnology to prevent and treat diseases. The nanomedicine market encompasses various applications, including drug delivery, in vivo imaging, in vitro diagnostics, biomaterials, and active implants. This market is driven by integrating nanoscale technologies into medicine, offering novel methods to diagnose and treat several illnesses with heightened efficacy and minimized adverse effects. Additionally, technological advancements in particle design, increased investments in nanotechnology research, and the consequent regulatory approvals are the factors promoting the utilization of nanomedicine in clinical trials. However, the nanomedicine market faces multiple challenges, including the high cost and complexity of nanomedicine development, issues surrounding the toxicity and biocompatibility of nanoparticles, and the lack of a clear regulatory framework. Furthermore, there are limitations associated with the large-scale manufacturing of nanomedicines and ensuring the stability of nanoparticles. The latest opportunities in nanomedicine are witnessed in personalized medicine, where nanotechnology is employed to tailor treatments according to individual genetic profiles. There is increasing interest in nanobots for precision surgery, targeted therapy, and nanoparticles for immune system modulation. Biodegradable nanostructures offer an environmentally friendly alternative for drug delivery vehicles. Nanofabrication techniques are also expected to revolutionize regenerative medicine by creating nanostructured scaffolds for tissue regeneration.
FPNV Positioning Matrix:
The FPNV Positioning Matrix is essential for assessing the Nanomedicine Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).
Market Share Analysis:
The Market Share Analysis offers an insightful look at the current state of vendors in the Nanomedicine Market. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.
Key Company Profiles:
The report delves into recent significant developments in the Nanomedicine Market, highlighting leading vendors and their innovative profiles. These include AMAG Pharmaceuticals, Inc., Amgen Inc., Arrowhead Pharmaceuticals, Inc., Bausch Health Companies Inc., Bayer Healthcare, Biogen Inc., Bristol-Myers Squibb Company, Celgene Corporation, Eisai Co Ltd, F. Hoffmann-La Roche AG, Galen Ltd, General Electric Company, Gilead Sciences, Inc., Ipsen SA, Jazz Pharmaceuticals plc, Lantheus Holdings, Inc., Leadient BioSciences Inc., Mallinckrodt Pharmaceuticals, Merck & Co., Inc., Nano spectra Biosciences, Inc., Novo Nordisk A/S, OSARTIS GmbH, Pacira BioSciences Inc., Pfizer Inc., Sanofi S.A., Taiwan Liposome Company, Ltd., Takeda Pharmaceutical Company Limited, Teva Pharmaceuticals Ltd., UCB SA, and Zimmer Biomet Holdings, Inc..
Inquire Before Buying @ https://www.360iresearch.com/library/intelligence/nanomedicine?utm_source=openpr&utm_medium=referral&utm_campaign=inquire
Market Segmentation & Coverage:
This research report categorizes the Nanomedicine Market in order to forecast the revenues and analyze trends in each of following sub-markets:
Based on Molecule Type, market is studied across Nanodevices, Nanoparticles, Nanoshells, and Nanotubes. The Nanoparticles is further studied across Dendrimers, Hydrogel Nanoparticles, Inorganic Nanoparticles, Liposomes, Metal & Metal Oxide Nanoparticles, and Polymers & Polymer Drug Conjugates. The Nanotubes is projected to witness significant market share during forecast period.
Based on Modality, market is studied across Diagnostics and Treatment. The Diagnostics is projected to witness significant market share during forecast period.
Based on Application, market is studied across Diagnostic Imaging, Drug Delivery, Implants, Regenerative Medicine, and Vaccines. The Regenerative Medicine is projected to witness significant market share during forecast period.
Based on Indication, market is studied across Clinical Cardiology, Clinical Oncology, Immunology, Infectious Diseases, Neurology, Ophthalmology, Orthopedics, and Urology. The Orthopedics is projected to witness significant market share during forecast period.
Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Asia-Pacific is projected to witness significant market share during forecast period.
Key Topics Covered:
1. Preface
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
6. Nanomedicine Market, by Molecule Type
7. Nanomedicine Market, by Modality
8. Nanomedicine Market, by Application
9. Nanomedicine Market, by Indication
10. Americas Nanomedicine Market
11. Asia-Pacific Nanomedicine Market
12. Europe, Middle East & Africa Nanomedicine Market
13. Competitive Landscape
14. Competitive Portfolio
15. Appendix
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Nanomedicine Market?
2. Which are the products/segments/applications/areas to invest in over the forecast period in the Nanomedicine Market?
3. What is the competitive strategic window for opportunities in the Nanomedicine Market?
4. What are the technology trends and regulatory frameworks in the Nanomedicine Market?
5. What is the market share of the leading vendors in the Nanomedicine Market?
6. What modes and strategic moves are considered suitable for entering the Nanomedicine Market?
Read More @ https://www.360iresearch.com/library/intelligence/nanomedicine?utm_source=openpr&utm_medium=referral&utm_campaign=analyst
Contact 360iResearch
Mr. Ketan Rohom
Sales & Marketing,
Office No. 519, Nyati Empress,
Opposite Phoenix Market City,
Vimannagar, Pune, Maharashtra,
India - 411014.
sales@360iresearch.com
+1-530-264-8485
+91-922-607-7550
About 360iResearch
360iResearch is a market research and business consulting company headquartered in India, with clients and focus markets spanning the globe.
We are a dynamic, nimble company that believes in carving ambitious, purposeful goals and achieving them with the backing of our greatest asset - our people.
Quick on our feet, we have our ear to the ground when it comes to market intelligence and volatility. Our market intelligence is diligent, real-time and tailored to your needs, and arms you with all the insight that empowers strategic decision-making.
Our clientele encompasses about 80% of the Fortune Global 500, and leading consulting and research companies and academic institutions that rely on our expertise in compiling data in niche markets. Our meta-insights are intelligent, impactful and infinite, and translate into actionable data that support your quest for enhanced profitability, tapping into niche markets, and exploring new revenue opportunities.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage
to this press release on woodPRI. woodPRI disclaims liability for any content contained in
this release.
Recommend
/newsMicroencapsulation Market Deep Analysis on Key Players - Dow Corning, Encapsys, Syngenta Crop Protection, Evonik Industries, 3M and Bayer
Market Study Report Adds Global Microencapsulation Market Size, Status and Forecast 2024 added to its database. The report provides key statistics on the current state of the industry and other analytical data to understand the market.
Extensive research is required for choosing the appropriate cor...
/newsGermany Airbag Market Size 2023: Global Share, Industry And Report Analysis By 2030 | Hyundai Mobis Co., Ltd. Key Safety Systems, Inc. Robert Bosch GmbH
Germany airbag market is expected to grow at a CAGR of around 6% during the forecast period. Germany Airbag Market research report refers to gathering and analyzing significant market data serve as best medium for various industry players to launch novel product or service. It is vital for key firms...
/newsSecurities Brokerages And Stock Exchanges Market Outlook 2021: Big Things are Happening
A new intelligence report released by HTF MI with title "Global Securities Brokerages And Stock Exchanges Market Survey & Outlook" is designed covering micro level of analysis by Insurers and key business segments, offerings and sales channels. The Global Securities Brokerages And Stock Exchange...
/newsRenewable Chemicals Market Emerging Trends and Competitive Landscape Forecast to 2028
The renewable chemicals market was valued at US$ 80,566.30 million in 2021 and is projected to reach US$ 1,76,750.76 million by 2028 it is expected to grow at a CAGR of 11.9% from 2021 to 2028. The research report focuses on the current market trends, opportunities, future potential of the market, a...
/newsHow Coronavirus is Impacting Cold Brew Coffee, Global Market Volume Analysis, Size, Share and Key Trends 2020-2026
"Market Latest Research Report 2020:
Los Angles United States, February 2020: The Cold Brew Coffee market has been garnering remarkable momentum in the recent years. The steadily escalating demand due to improving purchasing power is projected to bode well for the global market. QY Research's lates...
/newsCorporate E-Learning Market - Global Industry Size, Share, Key Players Analysis that are Infor, SkillSoft Corporation, Adrenna, CERTPOINT Systems and others with Regional Forecast to 2022
Overview:
E-Learning is used to enhance the learning procedures for newer job requirements and to make employees sound about the internal and external changes in the market and respective organizations. This method has created considerable differences in the ways of training and developing employee...
